{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T18:42:33Z","timestamp":1775673753599,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:00:00Z","timestamp":1493856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s10753-017-0561-1","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T06:23:35Z","timestamp":1493879015000},"page":"1177-1190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["N-(2-Hydroxyphenyl)acetamide: a Novel Suppressor of RANK\/RANKL Pathway in Collagen-Induced Arthritis Model in Rats"],"prefix":"10.1007","volume":"40","author":[{"given":"Anum","family":"Gul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal","family":"Kunwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mazhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kahkashan","family":"Perveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabana U.","family":"Simjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,4]]},"reference":[{"key":"561_CR1","first-page":"551","volume":"33","author":"V Picerno","year":"2015","unstructured":"Picerno, V., F. Ferro, A. Adinolfi, E. Valentini, C. Tani, and A. Alunno. 2015. One year in review: The pathogenesis of rheumatoid arthritis. Clinical and Experimental Rheumatology 33: 551\u2013558.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"561_CR2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I.B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine 365: 2205\u20132219.","journal-title":"New England Journal of Medicine"},{"key":"561_CR3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","volume":"43","author":"AJ MacGregor","year":"2000","unstructured":"MacGregor, A.J., H. Snieder, A.S. Rigby, M. Koskenvuo, J. Kaprio, K. Aho, and A.J. Silman. 2000. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis and Rheumatism 43: 30.","journal-title":"Arthritis and Rheumatism"},{"key":"561_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/ar136","author":"WB Berg van den","year":"2000","unstructured":"van den Berg, W.B. 2000. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Research & Therapy. doi: 10.1186\/ar136 .","journal-title":"Arthritis Research & Therapy."},{"key":"561_CR5","first-page":"412","volume":"47","author":"BA Freeman","year":"1982","unstructured":"Freeman, B.A., and J.D. Crapo. 1982. Biology of disease: Free radicals and tissue injury. Laboratory investigation; a journal of technical methods and pathology 47: 412\u2013426.","journal-title":"Laboratory investigation; a journal of technical methods and pathology"},{"key":"561_CR6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/biof.5520060404","volume":"6","author":"E Cadenas","year":"1997","unstructured":"Cadenas, E. 1997. Basic mechanisms of antioxidant activity. BioFactors 6: 391\u2013397.","journal-title":"BioFactors"},{"key":"561_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature01654","volume":"423","author":"G Karsenty","year":"2003","unstructured":"Karsenty, G. 2003. The complexities of skeletal biology. Nature 423: 316\u2013318.","journal-title":"Nature"},{"key":"561_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/rheumatology\/30.2.82","volume":"30","author":"A Woolf","year":"1991","unstructured":"Woolf, A. 1991. Osteoporosis in rheumatoid arthritis\u2014The clinical viewpoint. Rheumatology 30: 82\u201384.","journal-title":"Rheumatology"},{"key":"561_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","volume":"20","author":"T Suda","year":"1999","unstructured":"Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M.T. Gillespie, and T.J. Martin. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Reviews 20: 345\u2013357.","journal-title":"Endocrine Reviews"},{"key":"561_CR10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1146\/annurev.immunol.20.100301.064753","volume":"20","author":"LE Theill","year":"2002","unstructured":"Theill, L.E., W.J. Boyle, and J.M. Penninger. 2002. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annual Review of Immunology 20: 795\u2013823.","journal-title":"Annual Review of Immunology"},{"key":"561_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5312\/wjo.v4.i1.1","volume":"4","author":"S Tanaka","year":"2013","unstructured":"Tanaka, S. 2013. Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways. World Journal of Orthopedics 4: 1\u20136.","journal-title":"World Journal of Orthopedics"},{"key":"561_CR12","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/endo-123-5-2600","volume":"123","author":"N Takahashi","year":"1988","unstructured":"Takahashi, N., T. Akatsu, N. Udagawa, T. Sasaki, A. Yamaguchi, J.M. Moseley, T.J. Martin, and T. Suda. 1988. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123: 2600\u20132602.","journal-title":"Endocrinology"},{"key":"561_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11926-009-0027-z","volume":"11","author":"EM Lewiecki","year":"2009","unstructured":"Lewiecki, E.M. 2009. Denosumab for joints and bones. Current Rheumatology Reports 11: 196\u2013201.","journal-title":"Current Rheumatology Reports"},{"key":"561_CR14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/acr.20172","volume":"62","author":"JT Sharp","year":"2010","unstructured":"Sharp, J.T., W. Tsuji, P. Ory, C. Harper\u2010Barek, H. Wang, and R. Newmark. 2010. Denosumab prevents metacarpal shaft cortical bone loss in patients with erosive rheumatoid arthritis. Arthritis Care & Research 62: 537\u2013544.","journal-title":"Arthritis Care & Research"},{"key":"561_CR15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncprheum0036","volume":"1","author":"G Schett","year":"2005","unstructured":"Schett, G., S. Hayer, J. Zwerina, K. Redlich, and J.S. Smolen. 2005. Mechanisms of disease: The link between RANKL and arthritic bone disease. Nature Clinical Practice Rheumatology 1: 47\u201354.","journal-title":"Nature Clinical Practice Rheumatology"},{"key":"561_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/35005552","volume":"402","author":"Y-Y Kong","year":"1999","unstructured":"Kong, Y.-Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. Elliott, and S. McCabe. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402: 43\u201347.","journal-title":"Nature"},{"key":"561_CR17","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D., T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham, N.S. Birnbaum, G.R. Burmester, V.P. Bykerk, and M.D. Cohen. 2010. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology\/European league against Rheumatism collaborative initiative. Arthritis and Rheumatism 62: 2569\u20132581.","journal-title":"Arthritis and Rheumatism"},{"key":"561_CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11010-013-1873-6","volume":"387","author":"H Jawed","year":"2014","unstructured":"Jawed, H., S. Jamall, S.U.A. Shah, K. Perveen, F. Hanif, and S.U. Simjee. 2014a. N-(2-hydroxy phenyl) acetamide produces profound inhibition of c-Fos protein and mRNA expression in the brain of adjuvant-induced arthritic rats. Molecular and Cellular Biochemistry 387: 81\u201390.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"561_CR19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.intimp.2010.04.028","volume":"10","author":"H Jawed","year":"2010","unstructured":"Jawed, H., S.U.A. Shah, S. Jamall, and S.U. Simjee. 2010. N-(2-hydroxy phenyl) acetamide inhibits inflammation-related cytokines and ROS in adjuvant-induced arthritic (AIA) rats. International Immunopharmacology 10: 900\u2013905.","journal-title":"International Immunopharmacology"},{"key":"561_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-014-2082-7","volume":"394","author":"K Perveen","year":"2014","unstructured":"Perveen, K., F. Hanif, H. Jawed, S. Jamall, and S.U. Simjee. 2014. N-(2-hydroxy phenyl) acetamide: A novel suppressor of toll-like receptors (TLR-2 and TLR-4) in adjuvant-induced arthritic rats. Molecular and Cellular Biochemistry 394: 67\u201375.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"561_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1022453332560","volume":"23","author":"RS Ghirnikar","year":"1998","unstructured":"Ghirnikar, R.S., Y.L. Lee, and L.F. Eng. 1998. Inflammation in traumatic brain injury: Role of cytokines and chemokines. Neurochemical Research 23: 329\u2013340.","journal-title":"Neurochemical Research"},{"key":"561_CR22","first-page":"168","volume":"11","author":"JM McHugh","year":"2000","unstructured":"McHugh, J.M., and W.B. McHugh. 2000. Pain: Neuroanatomy, chemical mediators, and clinical implications. AACN Advanced Critical Care 11: 168\u2013178.","journal-title":"AACN Advanced Critical Care"},{"key":"561_CR23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejr.2011.07.002","volume":"33","author":"AM El-barbary","year":"2011","unstructured":"El-barbary, A.M., M.A.A. Khalek, A.M. Elsalawy, and S.M. Hazaa. 2011. Assessment of lipid peroxidation and antioxidant status in rheumatoid arthritis and osteoarthritis patients. The Egyptian Rheumatologist 33: 179\u2013185.","journal-title":"The Egyptian Rheumatologist"},{"key":"561_CR24","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0024-3205(01)00978-X","volume":"68","author":"A Hrab\u00e1k","year":"2001","unstructured":"Hrab\u00e1k, A., V. Vercruysse, I.L. Kah\u00e1n, and B. Vray. 2001. Indomethacin prevents the induction of inducible nitric oxide synthase in murine peritoneal macrophages and decreases their nitric oxide production. Life Sciences 68: 1923\u20131930.","journal-title":"Life Sciences"},{"key":"561_CR25","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","volume":"163","author":"LA Joosten","year":"1999","unstructured":"Joosten, L.A., M.M. Helsen, T. Saxne, F.A. van de Loo, D. Heineg\u00e5rd, and W.B. van den Berg. 1999. IL-1\u03b1\u03b2 blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-\u03b1 blockade only ameliorates joint inflammation. The Journal of Immunology 163: 5049\u20135055.","journal-title":"The Journal of Immunology"},{"key":"561_CR26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2014.10.575","volume":"79","author":"E McNeill","year":"2015","unstructured":"McNeill, E., M.J. Crabtree, N. Sahgal, J. Patel, S. Chuaiphichai, A.J. Iqbal, A.B. Hale, D.R. Greaves, and K.M. Channon. 2015. Regulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation. Free Radical Biology and Medicine 79: 206\u2013216.","journal-title":"Free Radical Biology and Medicine"},{"key":"561_CR27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/art.1780391010","volume":"39","author":"GW Cannon","year":"1996","unstructured":"Cannon, G.W., S.J. Openshaw, J.B. Hibbs, J.R. Hoidal, T.P. Huecksteadt, and M.M. Griffiths. 1996. Nitric oxide production during adjuvant\u2010induced and collagen\u2010induced arthritis. Arthritis and Rheumatism 39: 1677\u20131684.","journal-title":"Arthritis and Rheumatism"},{"key":"561_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0192-0561(98)00015-0","volume":"20","author":"S Tanaka","year":"1998","unstructured":"Tanaka, S., T. Matsui, T. Murakami, T. Ishizuka, M. Sugiura, K. Kawashima, and T. Sugita. 1998. Immunological abnormality associated with the augmented nitric oxide synthesis in adjuvant-induced arthritis. International Journal of Immunopharmacology 20: 71\u201384.","journal-title":"International Journal of Immunopharmacology"},{"key":"561_CR29","first-page":"1371","volume":"7","author":"M Tsubaki","year":"2015","unstructured":"Tsubaki, M., T. Takeda, T. Kino, T. Itoh, M. Imano, G. Tanabe, O. Muraoka, T. Satou, and S. Nishida. 2015. Mangiferin suppresses CIA by suppressing the expression of TNF-\u03b1, IL-6, IL-1\u03b2, and RANKL through inhibiting the activation of NF-\u03baB and ERK1\/2. American Journal of Translational Research 7: 1371\u20131381.","journal-title":"American Journal of Translational Research"},{"key":"561_CR30","doi-asserted-by":"crossref","first-page":"e59171","DOI":"10.1371\/journal.pone.0059171","volume":"8","author":"Z-F Wei","year":"2013","unstructured":"Wei, Z.-F., B. Tong, Y.-F. Xia, Q. Lu, G.-X. Chou, Z.-T. Wang, and Y. Dai. 2013. Norisoboldine suppresses osteoclast differentiation through preventing the accumulation of TRAF6-TAK1 complexes and activation of MAPKs\/NF-\u03baB\/c-Fos\/NFATc1 pathways. PloS One 8: e59171.","journal-title":"PloS One"},{"key":"561_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/ar2457","author":"KD Brown","year":"2008","unstructured":"Brown, K.D., E. Claudio, and U. Siebenlist. 2008. The roles of the classical and alternative nuclear factor-kappaB pathways: Potential implications for autoimmunity and rheumatoid arthritis. Arthritis Research & Therapy. doi: 10.1186\/ar2457 .","journal-title":"Arthritis Research & Therapy."},{"key":"561_CR32","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/clin.1997.4333","volume":"83","author":"PW Tsao","year":"1997","unstructured":"Tsao, P.W., T. Suzuki, R. Totsuka, T. Murata, T. Takagi, Y. Ohmachi, H. Fujimura, and I. Takata. 1997. The effect of dexamethasone on the expression of activated NF-\u03baB in adjuvant arthritis. Clinical Immunology and Immunopathology 83: 173\u2013178.","journal-title":"Clinical Immunology and Immunopathology"},{"key":"561_CR33","doi-asserted-by":"crossref","first-page":"13859","DOI":"10.1073\/pnas.95.23.13859","volume":"95","author":"AV Miagkov","year":"1998","unstructured":"Miagkov, A.V., D.V. Kovalenko, C.E. Brown, J.R. Didsbury, J.P. Cogswell, S.A. Stimpson, A.S. Baldwin, and S.S. Makarov. 1998. NF-\u03baB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proceedings of the National Academy of Sciences 95: 13859\u201313864.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"561_CR34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak, P.P., and G.S. Firestein. 2001. NF-\u03baB: A key role in inflammatory diseases. The Journal of Clinical Investigation 107: 7\u201311.","journal-title":"The Journal of Clinical Investigation"},{"key":"561_CR35","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1172\/JCI200422644","volume":"114","author":"SL Teitelbaum","year":"2004","unstructured":"Teitelbaum, S.L. 2004. RANKing c-Jun in osteoclast development. The Journal of Clinical Investigation 114: 463\u2013465.","journal-title":"The Journal of Clinical Investigation"},{"key":"561_CR36","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00109-004-0612-6","volume":"83","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi, H. 2005. Mechanistic insight into osteoclast differentiation in osteoimmunology. Journal of Molecular Medicine 83: 170\u2013179.","journal-title":"Journal of Molecular Medicine"},{"key":"561_CR37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/mol.109.057877","volume":"77","author":"J-H Lee","year":"2010","unstructured":"Lee, J.-H., H. Jin, H.-E. Shim, H.-N. Kim, H. Ha, and Z.H. Lee. 2010. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-\u03baB signal. Molecular Pharmacology 77: 17\u201325.","journal-title":"Molecular Pharmacology"},{"key":"561_CR38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI200419657","volume":"114","author":"F Ikeda","year":"2004","unstructured":"Ikeda, F., R. Nishimura, T. Matsubara, S. Tanaka, J.-i. Inoue, S.V. Reddy, K. Hata, K. Yamashita, T. Hiraga, and T. Watanabe. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. The Journal of Clinical Investigation 114: 475\u2013484.","journal-title":"The Journal of Clinical Investigation"},{"key":"561_CR39","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3349\/ymj.2015.56.4.1134","volume":"56","author":"L Zhang","year":"2015","unstructured":"Zhang, L., M. Yu, J. Deng, X. Lv, J. Liu, Y. Xiao, W. Yang, Y. Zhang, and C. Li. 2015. Chemokine signaling pathway involved in CCL2 expression in patients with rheumatoid arthritis. Yonsei Medical Journal 56: 1134\u20131142.","journal-title":"Yonsei Medical Journal"},{"key":"561_CR40","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.4049\/jimmunol.0903284","volume":"184","author":"A Hashiramoto","year":"2010","unstructured":"Hashiramoto, A., T. Yamane, K. Tsumiyama, K. Yoshida, K. Komai, H. Yamada, F. Yamazaki, M. Doi, H. Okamura, and S. Shiozawa. 2010. Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-\u03b1. The Journal of Immunology 184: 1560\u20131565.","journal-title":"The Journal of Immunology"},{"key":"561_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7941684","author":"Y Liu","year":"2016","unstructured":"Liu, Y., M. Li, Q. He, X. Yang, F. Ruan, and G. Sun. 2016. Periploca Forrestii Saponin ameliorates murine CFA-induced arthritis by suppressing cytokine production. Mediators of Inflammation. doi: 10.1155\/2016\/7941684 .","journal-title":"Mediators of Inflammation"},{"key":"561_CR42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1449","volume":"12","author":"CG King","year":"2006","unstructured":"King, C.G., T. Kobayashi, P.J. Cejas, T. Kim, K. Yoon, G.K. Kim, E. Chiffoleau, S.P. Hickman, P.T. Walsh, and L.A. Turka. 2006. TRAF6 is a T cell\u2013intrinsic negative regulator required for the maintenance of immune homeostasis. Nature Medicine 12: 1088\u20131092.","journal-title":"Nature Medicine"},{"key":"561_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imm.12123","volume":"140","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y., X. Wang, H. Yang, H. Liu, Y. Lu, L. Han, and G. Liu. 2013. Kinase AKT controls innate immune cell development and function. Immunology 140: 143\u2013152.","journal-title":"Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-017-0561-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-017-0561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-017-0561-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:57:18Z","timestamp":1692791838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-017-0561-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,4]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["561"],"URL":"https:\/\/doi.org\/10.1007\/s10753-017-0561-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,4]]}}}